2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one

LRRK2-IN-1 is a compound that functions as an inhibitor of leucine-rich repeat kinase 2 (LRRK2), a protein kinase associated with Parkinson's disease. It is a pyrimidobenzodiazepine derivative with a complex structure containing multiple amine, amide, and ether functional groups.